Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$600.2K
20.17K shares
What this filing means
REED ELIZABETH E plans to sell 20.17K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $600.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001950047-26-000918
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
20.17K
Shares to sell
$600.2K
Approx. market value
2.99K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
1/31/2026
2.99KTotal acquired2.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Not Applicable | 2.99K | — |
| Total | 2.99K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.17K
Market value
$230.5K
2/3/2026
—Completed
Units to sell
10K
Market value
$273.4K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.99K
Market value
$96.4K
2/4/2026
Total
Units
20.17K
Value
$600.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 7.17K | $230.5K | — | Completed |
1/20/2026 | 10K | $273.4K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 2.99K | $96.4K | NASDAQ | Planned |
| Total | 20.17K | $600.2K | ||